Davide Fattore

14PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 10, 2026
Perspectives on managing skin manifestations in cancer patients: a multidisciplinary mixed-method survey of oncologists and dermatologists.

Davide Fattore, Omalkhair Abulkhair, Ola M Reda Khorshid

|Oct 30, 2025
Prevention and management of cutaneous immune-related adverse events: EADV Task Force statement.

Davide Fattore, Zoe Apalla, Azael Freites-Martinez

|Sep 09, 2025
Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.

Azael Freites-Martinez, Zoe Apalla, Jerry Shapiro

|Oct 26, 2024
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.

Z Apalla, A Freites-Martinez, K Grafanaki

|Jul 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients.

Vasiliki A Nikolaou, Zoe Apalla, Cristina Carrera

|Dec 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement.

Z Apalla, V Nikolaou, D Fattore

Pageof 3

Frequent Collaborators

10 joint publications

Zoe Apalla

8 joint publications

Vassiliki Nikolaou

8 joint publications

Vincent Sibaud

8 joint publications

Azael Freites-Martinez